Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer
Open Access
- 4 February 2016
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 114 (4) , 417-426
Abstract
Background: Methods: Results: Conclusions:Keywords
This publication has 61 references indexed in Scilit:
- The Cell Surface Glycoprotein CUB Domain-containing Protein 1 (CDCP1) Contributes to Epidermal Growth Factor Receptor-mediated Cell MigrationJournal of Biological Chemistry, 2012
- High-grade serous ovarian cancer arises from fallopian tube in a mouse modelProceedings of the National Academy of Sciences, 2012
- Cellular Settings Mediating Src Substrate Switching between Focal Adhesion Kinase Tyrosine 861 and CUB-domain-containing protein 1 (CDCP1) Tyrosine 734Journal of Biological Chemistry, 2011
- Rethinking ovarian cancer: recommendations for improving outcomesNature Reviews Cancer, 2011
- VHL loss in renal cell carcinoma leads to up-regulation of CUB domain-containing protein 1 to stimulate PKCδ-driven migrationProceedings of the National Academy of Sciences, 2011
- CUB-domain–containing protein 1 (CDCP1) activates Src to promote melanoma metastasisProceedings of the National Academy of Sciences, 2011
- Proteolysis-induced N-terminal Ectodomain Shedding of the Integral Membrane Glycoprotein CUB Domain-containing Protein 1 (CDCP1) Is Accompanied by Tyrosine Phosphorylation of Its C-terminal Domain and Recruitment of Src and PKCδJournal of Biological Chemistry, 2010
- Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovaryThe Journal of Pathology, 2010
- Inhibition of Tumor Metastasis: Functional Immune Modulation of the CUB Domain Containing Protein 1Molecular Pharmaceutics, 2009
- The Catalogue of Somatic Mutations in Cancer (COSMIC)Current Protocols in Human Genetics, 2008